This study compared the effects of ad libitum (AL) overfeeding and moderate or marked dietary restriction (DR) on aged-related degenerative and proliferative changes of the endocrine pancreas in Sprague-Dawley (SD) rats. SD rats were fed Purina Certi ed Rodent Diet AL (group 1), DR at 72-79% of AL (group 2), DR at 68-72% of AL (group 3) or DR at 47-48% of AL (group 4) for 106 weeks. Interim necropsies were performed at 13, 26, and 53 weeks, after a 7-day 5-bromo-2-deoxyuridin e (BrdU)lled minipump implantation. Before each necropsy, glucose and serum insulin levels were measured. In addition to the routine histopathologi c examination performed in both sexes, determination of 9 pancreatic islet stereologic parameters was done in males at 13, 26, and 53 weeks. In AL-fed rats, early changes in the islet morphology occurred, which resulted in a high incidence of islet brosis, focal hyperplasias and adenomas by two years. DR was dose-proportionall y associated with decreased glucose and serum insulin levels, and delayed the onset, and decreased the incidence and severity of islet brosis and hyperplasia. Results of the stereology supported the histopathologi c and clinical chemistry ndings. It demonstrated that, compared to AL-fed rats, DR-fed rats had smaller pancreas, smaller pancreatic islets, smaller insulin secreting cell volumes, a lower degree of islet brosis and a lower islet cell BrdU labeling index, which correlated with a lower incidence of islet adenoma and carcinoma at study termination. Moderate and marked degrees of DR delayed the onset and severity of islet hyperplasia and brosis in a temporal-and dose-related manner. In contrast to marked DR, which dramatically prevented these changes, moderate DR delayed but not prevented onset of islet tumors. These ndings support the concept that moderate DR results in a better-controlled animal model with a lower incidence or delayed onset of chronic spontaneou s endocrine diseases in the rat bioassay.
INTRODUCTION
The most poorly controlled variable in rodent bioassays is excessive ad libitum (AL) food (caloric) intake (24) (25) (26) (27) (28) 32) . It is also the main cause of early development of spontaneous tumors and severe degenerative diseases, resulting in poor 2-year survival (4, 21, 26-28, 32, 46, 51) . Spontaneous age-related co-morbid changes reported in AL-fed Sprague-Dawley (SD) rats include obesity, chronic nephropathy, cardiomyopathy, exocrine pancreatic atrophy and brosis, pancreatic islet hyperplasia and brosis, and the early development of potentially lethal tumors in the pituitary and mammary glands (2, 3, 8, 16, 25, 28, 45) .
Whereas both genetic and environmental factors are involved in these changes, it has been shown that moderate dietary restriction (DR) signi cantly improves 2-year survival, controls adult body weight, and delays the onset of AL-related spontaneous diseases and tumors (19, 23, 28, 35, 37-43, 56, 58, 59, 61) . Although the mechanisms underlying these multiple effects are not fully understood, it appears that dietary (caloric) restriction acts by modulating the characteristics, but not the rate, of dietary fuel use by preventing long-term metabolic damages resulting from oxidation or glycation (39, 41, 42, 61) . These effects on cell metabolism may in part explain the life-span-prolonging action of DR.
Although the bene cial effects of DR on nephropathy, cardiomyopathy and reproductive function have been described in various rat strains (5, 6, 16, 28, 54) , DR temporal and dose-related effects on the endocrine pancreas have not been reported in detail. In AL-fed rats, beta cell hyperplasia and progressive brosis of enlarged islets develop with aging. These morphological alterations, associated with obesity, hyperglycemia, hyperinsulinemia and increased insulin resistance, result in the development of noninsulin-dependentdiabetes mellitus (NIDDM) (1, 33) . Although a protective effect of DR on age-related impairment in insulin secretion and glucose metabolism has been reported (29, 38, 49) , its effects on the histogenesis of endocrine pancreatic changes have not been fully investigated. This paper describes the temporal clinical pathologic and morphologic features of the bene cial effects of moderate or marked DR on agerelated pancreatic islet pathology seen in AL-overfed SD rats.
MATERIALS AND METHODS Animals
A total of 380 male and 380 female Sprague-Dawley [Crl:CD ® R (SD) IGS BR] rats were obtained from Charles River Laboratories, Raleigh, NC. The animals were 7 weeks old at the initiation of the study and weighed between 134 and 266 g. The rats were individually housed in stainless steel cages in an environmentally controlled room with a 12-hour light cycle. They were individually identi ed with biomedical implants and allocated to cages by a randomized columnar allocation scheme. The animals were assigned to 4 different treatment groups using a balanced random allocation scheme based on body weight. Each group consisted of 95 males and 95 females with 15/sex/group allocated for each 13-, 26-, and 53-week interim necropsy, and with 50/sex/group allocated to the 106-week nal necropsy. Survival of both sexes was directly related to food intake. The survival for the groups 1 (AL), 2, 3, and 4 males was 18, 44, 68, and 78%, respectively, and for the female groups was 18, 40, 56, and 82%, respectively (22) . The Institutional Animal Care and Use Committee approved all procedures at Merck Research Laboratories, West Point, PA.
Diet and Dietary Regimen
Purina Certi ed Rodent Diet was provided either AL (Group 1) or with approximately 72-79% of the adult AL intake (17 and 24 g/day to females and males, respectively) (Group 2), 68-72% of the adult AL intake (16 and 22 g/day for females and males, respectively) (Group 3), or 47-48% of the adult AL amount (11 and 14.5 g/day to females and males, respectively) (Group 4). Purina Certi ed Rodent Diet contained 21% of protein, 4.5% of lipid, 55% of carbohydrate and 4.1% of ber. The metabolizable energy was 3.1 kcal/g of diet. Drinking water was available AL. All rats were given daily 0.5% aqueous methylcellulose by oral gavage at a dosing volume of 5 ml/kg.
Clinical Evaluations
All rats were observed daily for clinical signs and weighed before the start of the study, once in study week 1, generally twice weekly through study week 13 and once a week thereafter. These clinical data will be reported separately. At each necropsy blood was collected from the vena cava in 15/rats/sex/group for determination of serum glucose and insulin levels.
Osmotic Minipump Implantation
One week prior to each necropsy, 10 rats/sex/group selected by a strati ed random allocation scheme were implanted with osmotic minipumps (model #2ML1, 2ML, Alza Corp, Palo Alto, CA) for the 7-day continuous delivery of 5-bromo-2 -deoxyuridine (BrdU; Sigma Chemical Co, St. Louis, MO). Prior to implantation, the minipumps were loaded with BrdU at a concentration of 50 mg/ml in a 0.5 N sodium bicarbonate solution. The loaded minipumps were surgically implanted in the subcutaneous tissue under iso urane anesthesia, via a small dorsal midline skin incision. The incisions were closed with surgical staples, and the rats were returned to their cages until scheduled necropsy.
Necropsy and Histopathology
At scheduled necropsies, following an overnight fast, all rats were killed by exsanguination under deep anesthesia and the minipumps were removed prior to obtaining terminal body weights, organ weights and tissue sampling. A complete gross examination was performed on all animals. Numerous tissues were weighed and samples were taken for histopathology. These data will be reported separately. Pancreas were weighed, xed in 10% neutral buffered formalin and processed. Five sections were taken to sample the xed pancreas to include two peribiliary segments, the duodenal segment, the small gastric segment, and the splenic segment for stereological evaluation. Additional samples were obtained of suspect lesions for histologic examination. Histological sections of paraplast embedded tissues sectioned at 5 l m were stained with hematoxylin and eosin for routine histopathologi c evaluation. Sections adjacent to those used for histopathology were immunostained for insulin and BrdU and quantitatively analysed to determine of several stereologic islet parameters. Immunostaining of BrdU-labeled islet cells was done with a mouse monoclonal antibody directed against BrdU (Becton-Dickinson concentration of 1/200). Immunostaining of insulin containing cells was done with a guinea pig polyclonal antibody directed against insulin (Biogenesisconcentration of 1/4000). The avidin-biotin-peroxidas e technique (Vector Elite Kit 6100) was used to reveal the immunohistochemical reactions. All antibodies used were commercially available, and the suppliers provided the characterization data, including the antibody speci cities. Insulinimmunostained sections were counterstained with Masson's trichrome.
Stereology of the Endocrine Pancreas
Nine parameters were used to quantify pancreatic islet changes, based on morphometric analyses of pancreas sections and calculations done according to the principles of stereology (57) . These analyses were performed at the 13-, 26-, and 53-week periods on the 10 males from groups 1, 3, and 4 that had been implanted for 7 days with BrdU minipumps.
For the determination of the islet diameter (d, l m), volume density (Vv%) of insulin secreting cells in the islets and Vv% of the brovascular tissue in islets, 50 pancreatic islets per animal (10 per section of pancreas) were analyzed on insulinimmunostained tissue sections at a magni cation of 250X. Determination of the islet diameter and insulin secreting cell volume density in islets was done using an automatic image analyzer (Imagenia 2000, Biocom, Lyon France). Determination of the volume density of the brovascular component in islets was done using the point counting method using a 100-point square grid (57) .
Determination of the numerical density per unit volume (Nv) of the islets was done on the same insulinimmunostained preparations by examining 25 microscopic elds per animal (5 per section of pancreas) at magni cation of 100X. The numerical density of islets per unit volume was calculated based on the number of islet per unit area and the mean islet diameter. The total number of islets per pancreas was calculated by multiplying the numerical density of islets by the volume of the pancreas, with the assumption that one gram of tissue is equal to one cubic centimeter. The labeling index (LI) of endocrine cell nuclei was determined on BrdU-immunostained sections by analyzing 50 microscopic elds within the endocrine islets at magnication of 400X and counting approximately 2,000 cells in islets per animal. The total number of labeled nuclei per pancreas was obtained by multiplying the numerical density of labeled nuclei per unit volume by the volume of the pancreas.
Statistical Analyses
Statistical analyses were performed on serum glucose and insulin levels, and pancreas stereologic parameters. These analyses were done in a logarithmic scale in order to satisfy the assumptions for continuous parameters that follow a continuous normal distribution. Each parameter was analyzed separately for each gender and necropsy interval. Tukey's studentized range test was used for the multiple comparisons among the 3 or 4 dietary groups (55) . The group averages were summarized by the geometric mean. 
RESULTS

Glucose and Insulin (Table 1)
Terminal serum glucose and insulin levels determined in fasted rats were generally lower in study weeks 13, 26, and 53 in DR-fed groups 3 and 4 (both sexes) than in the AL-fed group 1. However, the differences were statistically significant ( p < 0.05) only in the markedly DR-fed group 4 for glucose levels in study weeks 13 (male) and 53 (both sexes), and for insulin levels in study weeks 13, 26, and 53 (females only). At study termination, serum glucose and insulin levels were generally lower in DR-fed groups 3 and 4 than in AL-fed group 1, but no statistically signi cant differences were observed among groups. These data re ected the trends observed in the time-measured, tail-stick glucose levels from nonfasted rats (data to be published separately).
Histopathology (Table 2)
In all groups, the incidence and severity of islet changes were usually greater in males than in females in study weeks 13, 26, and 53.
Focal islet brosis was observed in study week 13, mainly in males. This change affected almost all group 1 AL-fed males in study week 26 and group 1 AL-fed females in study week 53. Fibrosis generally began in enlarged islets, and TOXICOLOGIC PATHOLOGY progressed with time, dissecting the islets into nests of insulin positive cells separated by bands of collagenous tissue (Figure 1 ). Mononuclear cell in ltration was sometimes associated with islet brosis. The ratio of brous tissue to islet cells increased with age, and in study week 53 some islets were reduced to isolated small nests of insulin positive cells surrounded by extensive brosis. The incidence and severity of this change was lower in DR-fed rats as compared to AL-fed rats. In moderately DR-fed group 3, islet brosis was not seen in females and lower in males in study weeks 26 ( Figure 2 ) and 53. In markedly DR-fed group 4, islet brosis was not present in study week 26 ( Figure 3 ), and affected only 20% of males at 53 weeks and 50% of males by 106 weeks.
Focal islet cell hyperplasia ( Figure 4 ) was observed in study week 53 in AL-fed group 1 (both sexes) and DR-fed group 2 (males only), and in all groups (both sexes) by study week 106. Hyperplasia affected a variable number of islets per section of pancreas, and consisted of hyperplastic islets up to 0.5 mm diameter without compression of surrounding acinar tissue. Enlarged islets have a normal cellular arrangement and may have cellular hypertrophy without atypia. In study week 53, islet cell hyperplasia was not observed in moderately or markedly DR-fed groups 3 and 4. By study week 106, the group 3 and 4 DR-fed females and group 4 DR-fed males had a lower incidence of this change than their AL-fed counterparts.
Pancreatic islet cell adenomas and carcinomas were observed in 2-year-old animals in all groups and in both sexes. Adenomas occurred more frequently than carcinomas, and generally were solitary nodules 1 to 10 mm diameter ( Figure 5 ) compressing the surrounding tissue. Cellular growth patterns show some pleomorphism, variable vascularization, and minimal atypia. Carcinomas were usually solitary nodules 5 to 10 mm in diameter or greater. They had a heterogeneous growth pattern with marked cellular anaplasia and pleomorphism. Encapsulation is seen but invasion of the brous capsule is the most common indication of malignancy. Invasion of lymphatics and blood vessels was less commonly seen. Group 1 AL-fed rats had an increased age-adjusted incidence of islet cell-tumors in both sexes. There was a statistically signi cant ageadjusted decreased incidence of islet cell adenomas in female groups 2, 3, and 4 and male group 4, and a statistically signi cant decrease in the incidence of islet cell carcinomas in the group 3 DR-fed males. However, the groups 2 and 3 DR-fed males had a higher incidence of islet hyperplasia and adenomas and a better survival than group 1 AL-fed males, suggesting a delay in the onset of these tumors in the moderately DR-fed male groups ( Table 2) . Stereology (Table 3) The results of pancreas parameters are shown in Table 3 . The pancreas weight re ected the total daily food intake and body growth (28) and was statistically signi cantly ( p 0.05) lower in DR-fed groups 3 and 4 than in AL-fed group 1 in study weeks 13, 26, and 53. DR-related decreases in the relative pancreas weights were also observed in both sexes, when expressed as percent of the brain weights. At 106 weeks, the decreases in relative pancreas weights in groups 2, 3, and 4 were respectively 3.5, 3.5, and 32.3% in females and 15.7, 24.8, and 25.6% in males.
In all groups the diameter of islets increased with aging. This change was greater in the AL-fed group 1, where islet enlargement was reported at histopathology from week 26, onward. In DR-fed groups 3 and 4, the diameter of islets was slightly lower than in AL-fed group 1, the difference being statistically signi cant ( p 0.05) only in markedly DR-fed group 4 in study weeks 26 and 53.
The number of islets per cubic millimeter of pancreas was not statistically signi cantly different among groups. Therefore, the absolute number of islets per pancreas re ected differences in pancreas volume. It was (generally) lower in DRfed groups 3 and 4 than in the AL-fed group 1 in study weeks 13, 26, and 53; however, this difference was statistically signi cant ( p 0.05) only in markedly group 4 DR-fed males in study week 26. In study week 13, the volume fraction (Vv%) of insulin secreting cells in islets was statistically signi cantly ( p 0.05) lower in moderately and markedly DR-fed groups 3 and 4 than in the AL-fed group 1. Inversely, in study weeks 26 and 53, the Vv% of insulin secreting cells was greater in DR-fed groups 3 and 4 than in the AL-fed group 1. At these time points, the Vv% of insulin secreting cells in AL-fed group 1 decreased due to the development of islet brosis.
The absolute volume of insulin secreting cells in the pancreas re ected differences in islet diameter and pancreas volume. In the AL-fed group 1, this parameter increased from study week 13 to study week 26, and remained stable afterwards. It was statistically signi cantly ( p 0.05) lower in the markedly DR-fed group 4 than in the ALfed group 1 or moderately DR-fed group 3 in study weeks 13, 26, and 53. However, when the insulin secreting cell volume was expressed as a percentage of body weight, no statistically signi cant difference was observed among groups.
The islet cell labeling index (LI) was lower in markedly DR-fed group 4 than in AL-fed group 1 or moderately DR-fed group 3 at each period; however, the difference was statistically signi cant ( p 0.05) only in study week 53 (Figures 6  and 7 ). Higher LI determined in the AL-fed group 1 and DR-fed group 3 in study week 53 correlated with higher incidence of tumors in study week 106. The absolute number of labeled islet cell nuclei in the pancreas was lower in DR-fed groups 3 and 4 than in AL-fed-group 1 in study weeks 13, 26, and 53. The difference, however, was statistically signi cant ( p 0.05) only in markedly DR-fed group 4 in study weeks 26 and 53. The volume fraction of the brovascular tissue in islets increased in AL-fed group 1 from study week 13 to study week 26, and remained stable in study week 53. The islet fraction occupied by the brovascular tissue appeared lower in the moderately and markedly DR-fed groups 3 and 4 in study weeks 13, 26, and 53. This difference was statistically signi cant except in group 3 in study week 53, due to high interindividual variations. This result is consistent with the histopathological ndings, the highest incidence and severity of islet brosis being observed in male rats from the AL-fed group 1.
DISCUSSION
The age-related degenerative and proliferative changes observed in pancreatic islets in AL-fed SD rats, in this study, were similar to those previously observed in laboratory rats (1, 8, 13, 14, 18, 44, 50, 53 ). They consisted of early brosis and degeneration of islet cells leading to the development of focal hyperplasias, adenomas and carcinomas. Incidence of islet cell brosis observed at 106 weeks in AL-fed rats was higher in males than in females; however, incidence of tumors at this period was slightly higher in females. These results differed from those observed in a similar previous study (28) or reported in various rat strains (3, 8, 20) , where incidence of tumors were generally higher in males than in females. However, in both sexes focal brosis and hyperplasia occurred at earlier time points that correlate with the relative incidence of brosis, hyperplasia, and islet cell tumors at the terminal necropsy.
In male groups that were studied stereologically, early morphologic changes that were predictive of early development of disease processes, were observed in the pancreatic islets in AL-fed rats. As early as in study week 13, the mean islet diameter, the total volume of insulin-secreting cells and the brovascular index were greater in the AL-fed group 1 than in DR-fed groups 3 and 4. In study week 26, the brovascular index had increased markedly in AL-fed rats and was associated histologically with a high incidence of isletbrosis. The effects of moderate and marked DR on these early changes were not of similar magnitude. Compared to AL-fed rats, most of the islet stereologic parameters were mildly decreased by moderate DR but dramatically decreased by marked DR. The differences observed between the AL and marked DR groups were generally statistically signi cant. Similar ndings have been observed in other organ systems. For instance, early changes in glomerular stereologic parameters have been observed in the kidneys of AL-fed animals that were predictive of early onset of severe chronic renal disease (16, 22) .
In SD rats, the age-related morphological changes in pancreatic islets have been associated with metabolic alterations: from 3.5 to 17 months, progressive islet cell hyperplasia and brosis correlated with increased triglycerides, cholesterol, and glucose (8) , and at 12 months islet brosis and enlargement was associated with hyperinsulinism and obesity (17, 18, 48) . In this study insulin serum levels increased in females only, from 13 to 53 weeks. During this period fasting glucose serum levels remained stable in both sexes, and decreased fasting glucose and insulin levels were observed at 106 weeks, which is consistent with reports by others (48) . However, blood glucose levels peak in all AL and DR fed animals at the time of feeding, but these levels are reported to be signi cantly higher in AL than DR fed rodents. If the AL-fed animals are fasted, as was done in this study, glucose levels in AL rodents would fall to their lowest levels. Glucose levels in AL rodents have been reported to fall below fasting levels of DR rodents under these conditions (9) .
In the present experiment, the structural and functional modi cations observed in islets of old obese AL-fed rats resembled those reported in various experimental models of human diabetes. Age-related islet hyperplasia and brosis develop in the hyperinsulinemic obese Zucker rat (33) . In diabetic spiny mice, islet hyperplasia occurs with obesity but not brosis (15) .
Similarities and differences exist in pancreatic islet changes in old rats and human type II diabetes (NIDDM). NIDDM is characterized by a defect of beta cell adaptation to insulin resistance and is manifested clinically by hyperglycemia, hyperinsulinism and obesity (7) . Although the pancreatic islet pathology is extremely variable in diabetic patients (16) , moderated changes in beta cells, islet brosis and amyloidosis are commonly reported. In SD rats, beta cell hyperplasia and islet enlargement occur with aging, and have been attributed to an increased demand for insulin resulting from insulin resistance and/or glucose intolerance (17) . In older animals, these changes can evolve to beta cell atrophy and islet brosis, leading ultimately to decreased serum insulin levels, as observed in the present study and others (47, 48) .
The pathogenesis of age-related degenerative changes in pancreatic islets is not known. However, studies on the basic metabolic and cellular processes have led to general theories that implicate oxygen free radicals and glycation reactions, deriving from normal metabolic activities, as causative factors of age-related disorders (38, 61) . The alteration of these physiologic processes is likely to contribute to the development of degenerative diseases in many sites including the pancreas.
In addition, normal glucose metabolism can have long term negative consequences for the organism (38) . Glucose undergoes a nonenzymatic reaction with amino groups of proteins called the glycation reaction, which results in cross-linking of numerous proteins by modi ed glucose residues (38, 40, 42, 61) . The importance of this reaction is related to the plasma glucose levels in NIDDM patients; the levels of glycated proteins increase with plasma glucose levels (41) . This process may also contribute to islet degeneration and proliferation.
The multiple mechanisms by which AL-overfeeding enhances tumorigenesis in other organs may apply to the tumors of the pancreatic islets (10, 11, 19, 24, 30, 52, 58, 61) . Sustained replication rate and alterations in cell structure and metabolism are thought to be key factors of carcinogenesis (19, (26) (27) (28) 61) . In AL-fed rats, high caloric regimens result in increased cell division and DNA synthesis in many tissues. In the present study, the BrdU nuclear labeling index in islets was high in study week 53 in AL-fed rats, and statistically signi cantly higher than in the marked DR-fed rats.
Metabolic and hormonal changes have also been implicated as contributing factors to neoplasia. In aging rat, the development of insulin resistance and/or glucose intolerance induces an increased demand for insulin, resulting in compensatory beta cell hyperplasia and islet enlargement (17) . In this study, a 30% increase in mean islet diameter occurred in the AL-fed group between study week 13 and study week 53, and a high incidence of focal hyperplasias was observed by study week 106. In addition, AL overfeeding is associated with high levels of growth promoting hormones, such as insulin, IGF-1, and prolactin, and decreases in growth controlling adrenal corticoids, that may also contribute to the development of proliferative changes in the pancreatic islets (24, 39) .
Caloric restriction improves survival and lowers the incidence and severity of many diseases associated with overfeeding (26, 28) . In the present study, both moderate and marked DR decreased the incidence and severity of the degenerative and proliferative islet changes. The effects of moderate and marked DR were, however, different, as previously described for other tissues (25, 28) . Early changes in islet parameters, including islet diameter, total number of islets per pancreas, total volume of insulin secreting cells per pancreas and the brovascular index were statistically signi cantly decreased in the markedly DR-fed group. The incidence of islet brosis was reduced in moderately restricted rats, when compared to AL-fed rats, but was observed in study week 26, while under marked DR, islet brosis and hyperplasia were not observed, in either sex, until study week 53 and 106, respectively. The incidence of islet adenomas was also decreased in markedly restricted rats, when compared to ALfed rats. In the DR-fed group 4, only 2% of females and 8% of males had pancreatic adenomas by study week 106, compared to 24% in females and 18% in males in the AL-fed group 1. The effects of DR on islet cell tumors appeared to be different between the sexes: in females, islet cell hyperplasia and neoplasia were clearly reduced by moderate and marked DR, yet in males these changes were signi cantly reduced only by marked DR. Moderately DR-fed groups 2 and 3 males had a higher nal incidence of islet cell hyperplasia and adenoma than AL-fed group 1. This re ects the longer life span of these groups compared to their AL counterparts and although indicating a delay in onset of these lesions, they nevertheless develop in the moderate DR-fed groups. However, severe DR prevented the development of these tumors in males during the 2-year time span. These results show that moderate DR, in contrast to severe DR, does not prevent the occurrence of pancreatic islet tumors but rather, by increasing survival, allows these late-onset tumors to develop.
The protective effect of DR on islet morphology in SD rats was associated with lower terminal plasma glucose and insulin levels. Similar effects have been reported in other strains or rodent species (29, 38, 48) . In Fisher 344 rats, DR reduced glucose and insulin levels, decreased the incidence of spontaneous age-related diseases and increased longevity (38, 58, 59) . In male obese Zucker rats, DR reduced the incidence of clinical and islet histopathological changes (39) . Caloric restricted mice had signi cantly smaller pancreatic islets and lower plasma glucose levels than AL-fed mice (29) .
The mechanism of action of DR on glucose metabolism has been investigated in rodents. It has been shown that DR rats were less insulin resistant than AL-fed rats, and it was suggested that DR increases glucose effectiveness or insulin sensitivity (38, 49) . Because hyperglycemia inhibits insulin action due to a decrease in translocation of glucose transporters in cell membranes, it was hypothesized that DR increases glucose transporters and then lowers plasma glucose and insulin levels (36, 38) . The metabolic use of lower concentrations of glucose is thought to be less damaging over the life span of the organism (25, 26) .
In this study, a statistically signi cant decrease in the insulin secreting cell volume was determined in the pancreas of the markedly DR-fed rats in study weeks 13, 26, and 53. Lower serum glucose and insulin levels observed in DR-fed rats were associated with lower brovascular index measured by stereology, and with lower incidence and severity of focal hyperplasias and adenomas observed at histopathology by study week 106. AL-fed SD rats develop pancreatic islet cell hyperplasia and insulin hypersecretion that lead to islet cell degeneration and brosis prior to the rst year of life (26, 28) . These changes can lead to an increased incidence of islet cell tumors in the AL-fed rats, relative to their moderate DR-fed counterparts (24, 28) . The effects of moderate food restriction on lowering plasma glucose levels and increasing insulin ef ciency may be a fundamental mechanism resulting in an ef cient use of glucose that appear less damaging over the life span of the organism (24, 39, 40, 61) . In the present study, decreased incidence of pancreatic changes associated with decreased glucose level support this hypothesis.
In addition to its bene cial effects on glucose and oxidative metabolism, DR might have a direct effect on tumorigenesis by modulating cell proliferation, hormone levels and DNA repair mechanisms. DR is thought to partially inhibit cell proliferation, a key factor in carcinogenesis (34) , therefore delaying tumor onset. In this study, islet BrdU labeling index was statistically signi cantly reduced in markedly DR-fed rats in study week 53, and a low incidence of islet adenomas was observed in this group by 106 weeks. It is probable that the effect of DR on cell proliferation depends on its degree as well as its duration and time of onset (60) . Moreover decreased insulin levels may delay the onset of pancreatic tumors by delaying early proliferation in the islets.
In conclusion, long term AL overfeeding of SD rats resulted in early changes in the pancreatic islet morphology, which correlated with high serum glucose and insulin levels, and were predictive of the early development of disease processes. This was associated with a high incidence of islet brosis, focal hyperplasias and adenomas by 2 years. Diet (caloric) restriction decreased incidence and severity of degenerative and proliferative pancreatic islet changes and early development of tumors, in association with decreased glucose and insulin levels. In contrast to severe DR (50% of AL), which dramatically prevented these changes, moderate DR (75% of AL) delayed but not prevented onset of islet tumors. Finally, these ndings support the concept that moderate DR provides a better-controlled animal model with a lower incidence or delayed onset of chronic spontaneous endocrine diseases in the rat bioassay.
